SHL Telemedicine Ltd.'s latest marketcap:
As of 07/28/2025, SHL Telemedicine Ltd.'s market capitalization has reached $33.34 M. According to our data, SHL Telemedicine Ltd. is the 32954th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 33.34 M |
| Revenue (ttm) | 64.2 M |
| Net Income (ttm) | -31,768,314.2 |
| Shares Out | 16.39 M |
| EPS (ttm) | -1.94 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 04/10/2019 |
| Earnings Date | 09/11/2025 |
SHL Telemedicine Ltd.'s yearly market capitalization.
| Date | Market Cap(₣) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/28/2025 | ₣26.72 M | $33.34 M | -37.31% | 32954 |
| 12/30/2024 | ₣42.62 M | $46.93 M | -62.59% | 28427 |
| 12/29/2023 | ₣113.92 M | $135.31 M | -47.37% | 21174 |
| 12/30/2022 | ₣216.45 M | $234 M | -21.67% | 17088 |
| 12/30/2021 | ₣276.35 M | $302.9 M | 121.1% | 16406 |
| 12/30/2020 | ₣124.99 M | $141.17 M | 118.35% | 18623 |
| 12/30/2019 | ₣57.24 M | $59.08 M | -10.6% | 20970 |
| 12/28/2018 | ₣64.03 M | $65.19 M | -3.28% | 19537 |
| 12/29/2017 | ₣66.2 M | $67.85 M | -7.87% | 20005 |
| 12/30/2016 | ₣71.85 M | $70.42 M | 8.21% | 17640 |
Company Profile
About SHL Telemedicine Ltd.
SHL Telemedicine Ltd., along with its subsidiaries, specializes in developing and marketing advanced personal telemedicine solutions across Israel, Europe, and international markets.
Key Products & Services
- SmartHeart: A mobile 12-lead ECG device designed for early heart attack detection.
- CardioSen’C: A cellular-digital 12-lead ECG transmitter for remote diagnostics.
- Cardio’B: A portable 12-lead ECG transmission device.
- Central Communication Module: A telecommunication hub that relays medical data (blood pressure, oxygen levels, glucose readings, etc.) to telemedicine centers.
- TelePress: A remote blood pressure monitoring device for personal use.
Target Audience
The company serves a diverse clientele, including physicians, hospitals, health insurance providers, and patients, leveraging electronic and telecommunication technologies for seamless healthcare delivery.
Strategic Collaborations
SHL Telemedicine has partnered with:
- Mayo Clinic: To assess post-heart attack patient outcomes using SmartHeart technology.
- Hebrew University of Jerusalem & Hadassah Medical Center: For research and development initiatives.
Founded: 1986 | Headquarters: Tel Aviv, Israel
Frequently Asked Questions
-
What is SHL Telemedicine Ltd.'s (SWX-SHLTN) current market cap?As of 07/28/2025, SHL Telemedicine Ltd. (including the parent company, if applicable) has an estimated market capitalization of $33.34 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does SHL Telemedicine Ltd. (SWX-SHLTN) rank globally by market cap?SHL Telemedicine Ltd. global market capitalization ranking is approximately 32954 as of 07/28/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.